Giving clinicians the choices they want for respiratory function and advanced parameter monitoring technologies is an essential part of any successful medical device strategy today.
That’s why Medtronic offers ready access to our market-leading technology portfolio for OEM Strategic Partners whose customers ask for the clinical reference standard in brain monitoring (BIS™) and cerebral/somatic oximetry (INVOS™) and a high-performing, trusted market leader in pulse oximetry (Nellcor™) and capnography (Microstream™).
With Medtronic OEM Monitoring Solutions, you get the only monitoring technology partnership that offers integration-ready OEM platforms for each of its leading monitoring parameters—all from a single source.
Nellcor™ cardiac-based pulse oximetry delivers accurate and trusted SpO2 and respiratory monitoring for patients at all acuity levels. It provides:
Designed for accuracy, Microstream™ technology uses CO2-specific Molecular Correlation Spectroscopy™ (MCS) and Uni-junction sampling line technology to deliver clear, crisp waveforms and accurate etCO2 and respiration rate measurements.
Engineered for use on both intubated and non-intubated patients, Microstream™ technology with its broad portfolio of patient-interface solutions can be used with virtually all patient populations and clinical environments. And, the Smart Capnography™ suite of algorithms are proven to reduce alarms and/or simplify the use of capnography monitoring, including: Smart Breath Detection™, Smart Alarm for Respiratory Analysis™ (SARA™), Integrated Pulmonary Index™ (IPI) algorithm and the new Apnea-Sat Alert™ algorithm.
Indicated for patients of any age or weight, INVOS™ cerebral/somatic oximetry provides real-time measurement and display of regional oxygen saturation (rSO2) in the vasculature beneath the sensor, to help clinicians assess site-specific adequacy of perfusion in the brain and vital organ areas.
The clinical standard in regional oximetry, the INVOS™ system is the only cerebral/somatic oximeter with rigorous, peer-reviewed clinical investigations (more than 600) and the demonstrated ability to improve patient outcomes.
Using EEG signals and the scientifically validated Bispectral Index™ technology, also known as BIS™ technology. BIS™ brain monitoring helps clinicians customise anaesthetic dosing to individual physiologies in every phase of anaesthesia.
BIS™ technology is the most widely studied and published of its kind, and is proven to improve anaesthesia-related clinical outcomes. It has FDA cleared indications for helping reduce awareness and anaesthetic consumption. With advanced bilateral features and 4-channel EEG monitoring, BIS brain monitoring technology provides the capability to detect hemispheric differences in the brain.
*Motion tolerance claims do not apply to Respiration Rate.